Digestive Remedies in Brazil

Summary

Euromonitor International's Digestive Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2001-2006), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2011 illustrate how the market is set to change.

Product coverage: Indigestion and heatburn remedies, laxatives, diarrhoeal remedies, motion sickness remedies, child-specific digestive remedies Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

• Get a detailed picture of the digestive remedies industry
• Pinpoint growth sectors and trends and identify factors driving change
• Understand the competitive environment, the market's major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai and Vilnius and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

• Executive Summary
  • Stagnating Sales in 2006
  • Ageing Population Requires More Medical Care
  • Distribution System under Fire
  • Market Concentration Continues
• Key Trends and Developments
  • Demographics: Increasing Life Expectancy Creates Additional Demand
  • Increasing Health Awareness of German Consumers
  • German Distribution System under Fire
  • Switching Activity
  • Market Concentration Continues
• Market Indicators
• Market Data
• Appendix
  • Otc Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Generics
  • Consumer Expenditure on Health Goods and Medical Services
• Definitions
• Sources
• Local Company Profile - Germany
  • Bayer Ag - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Beiersdorf Ag - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Boehringer Sohn, Ch - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Glaxosmithkline Plc - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Johnson & Johnson Inc - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Mcm Klosterfrau Vertriebsgesellschaft Mbh - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Novartis Ag - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Ratiopharm Gmbh & Co - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
  • Stada Arzneimittel Ag - Otc Healthcare - Germany
    • Strategic Direction
    • Key Facts
    • Company Background
    • Production
    • Competitive Positioning
    • Medicated skin care in Germany
    • Headlines
    • Trends
    • Competitive Landscape
    • Prospects
    • Sector Data
• List of Summaries
  • Summary 1 Research Sources
  • Summary 2 Bayer Healthcare Ag: Key Facts
  • Summary 3 Bayer Healthcare: Operational Indicators (Global)
  • Summary 4 Bayer Ag: Competitive Position 2006
  • Summary 5 Beiersdorf Ag: Key Facts
  • Summary 6 Beiersdorf Ag: Operational Indicators (Global)
  • Summary 7 Beiersdorf Ag: Competitive Position 2006
  • Summary 8 Boehringer Ingelheim Pharma Gmbh & Co Kg: Key Facts
  • Summary 9 Boehringer Sohn Ch: Operational Indicators (Global)
  • Summary 10 Boehringer Sohn Ch: Competitive Position 2006
  • Summary 11 Glaxosmithkline Gmbh & Co Kg: Key Facts
  • Summary 12 Glaxosmithkline Plc: Operational Indicators (Global)
  • Summary 13 Glaxosmithkline Plc: Competitive Position 2006
  • Summary 14 Johnson & Johnson Gmbh: Key Facts
  • Summary 15 Johnson & Johnson Inc: Operational Indicators (Global)
  • Summary 16 Johnson & Johnson Inc: Competitive Position 2006
  • Summary 17 Mcm Klosterfrau Vertriebsgesellschaft Mbh: Key Facts
  • Summary 18 Mcm Klosterfrau Vertriebsgesellschaft Mbh: Competitive Position 2006
  • Summary 19 Novartis Deutschland Gmbh: Key Facts
  • Summary 20 Novartis Ag: Operational Indicators (Global)
  • Summary 21 Novartis Ag: Competitive Position 2006
  • Summary 22 Ratiopharm Gmbh & Co: Key Facts
  • Summary 23 Ratiopharm Gmbh & Co: Operational Indicators (Global)
  • Summary 24 Ratiopharm Gmbh & Co: Competitive Position 2006
  • Summary 25 Stada Arzneimittel Ag: Key Facts
  • Summary 26 Stada Arzneimittel Ag: Operational Indicators (Global)
  • Summary 27 Stada Arzneimittel Ag: Competitive Position 2006
• List of Tables
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
  • Table 2 Life Expectancy at Birth 2001-2006
  • Table 3 Sales of Otc Healthcare by Sector: Value 2001-2006
  • Table 4 Sales of Otc Healthcare by Sector: % Value Growth 2001-2006
  • Table 5 Otc Healthcare Company Shares by Retail Value 2002-2006
  • Table 6 Otc Healthcare Brand Shares by Retail Value 2003-2006
  • Table 7 Penetration of Private Label by Sector 2002-2006
  • Table 8 Sales of Otc Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 9 Sales of Otc Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 10 Forecast Sales of Otc Healthcare by Sector: Value 2006-2011
  • Table 11 Forecast Sales of Otc Healthcare by Sector: % Value Growth 2006-2011
  • Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
  • Table 13 Sales of Medicated Skin Care by Subsector: Value 2001-2006
  • Table 14 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
  • Table 15 Herbal vs Standard Medicated Skin Care 2001/2006
  • Table 16 Medicated Skin Care Company Shares by Retail Value 2002-2006
  • Table 17 Medicated Skin Care Brand Shares by Retail Value 2003-2006
  • Table 18 Acne Treatments Brand Shares by Retail Value 2003-2006
  • Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
  • Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011